The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)922.00
  • Today's Change15.00 / 1.65%
  • Shares traded51.41k
  • 1 Year change+21.00%
  • Beta0.6067
Data delayed at least 20 minutes, as of Nov 22 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year The Biotech Growth Trust PLC grew revenues -- from -36.18m to 79.73m while net income improved from a loss of 41.30m to a gain of 74.60m.
Gross margin94.75%
Net profit margin93.57%
Operating margin93.77%
Return on assets19.33%
Return on equity21.57%
Return on investment21.57%
More ▼

Balance sheet in GBPView more

The Biotech Growth Trust PLC has a Debt to Total Capital ratio of 11.53%.
Current ratio0.3326
Quick ratio--
Total debt/total equity0.1303
Total debt/total capital0.1153
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 301.92%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)39.80
EPS (TTM) vs
TTM 1 year ago
305.67
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.